EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Intravenous regional guanethidine blockade in the treatment of post-traumatic complex regional pain syndrome type 1 (algodystrophy) of the hand



Intravenous regional guanethidine blockade in the treatment of post-traumatic complex regional pain syndrome type 1 (algodystrophy) of the hand



Journal of Bone and Joint Surgery. British Volume 84(3): 380-386



A total of 57 patients, aged between 23 and 86 years, with complex regional pain syndrome (CRPS) type 1 nine weeks after an isolated closed fracture of the distal radius, was randomised to receive either serial intravenous regional blockade (IVRB) with 15 mg of guanethidine in 30 ml of 0.5% prilocaine or serial IVRB with 30 ml of normal saline at weekly intervals until the tenderness in their fingers had resolved or they had received a maximum of four IVRBs. The analgesic efficacy was assessed at 24 hours, 48 hours and one week after each procedure by the dolorimetry ratio and verbal pain scores, and at intervals up to six months after the fracture. There was no significant difference in the number of IVRBs administered or in finger tenderness, stiffness or grip strength between the two groups. The guanethidine group experienced more pain in the affected hand (p = 0.025) and at six months had more vasomotor instability (p < 0.0001) compared with the control group. IVRB using guanethidine offers no significant analgesic advantage over a normal saline placebo block in the treatment of early CRPS type 1 of the hand after fracture of the distal radius. It does not improve the outcome of this condition and may delay the resolution of vasomotor instability when compared with the placebo.

(PDF emailed within 0-6 h: $19.90)

Accession: 046458807

Download citation: RISBibTeXText

PMID: 12002497

DOI: 10.1302/0301-620X.84B3.11901



Related references

Treatment of complex regional pain syndrome type I of the hand with a series of intravenous regional sympathetic blocks with guanethidine and lidocaine. Clinical Rheumatology 25(5): 687-693, 2005

Intravenous regional blocks with guanethidine and prilocaine combined with physiotherapy: two children with complex regional pain syndrome, type 1. European Journal of Anaesthesiology 19(5): 384-386, 2002

Intravenous regional guanethidine block without local anaesthesia for complex regional pain syndrome. Pain Practice 11(5): 506; Author Reply 506-7, 2012

Complex Regional Pain Syndrome Revived by Epileptic Seizure Then Disappeared Soon during Treatment with Regional Intravenous Nerve Blockade: A Case Report. Anesthesiology Research and Practice 2011: 494975-494975, 2011

Treatment of algodystrophy with regional intravenous block using guanethidine. Cahiers D'anesthesiologie 36(3): 183-190, 1988

Treatment of algodystrophy by regional block with intravenous guanethidine. Revue du Rhumatisme et des Maladies Osteo-Articulaires 49(12): 867-869, 1982

Treatment of algodystrophy using intravenous guanethidine regional block. Annales de Chirurgie de la Main 1(1): 57-64, 1982

Biopsychosocial complexity is correlated with psychiatric comorbidity but not with perceived pain in complex regional pain syndrome type 1 (algodystrophy) of the knee. Joint, Bone, Spine 78(2): 194-199, 2011

Diagnosis of post-traumatic complex regional pain syndrome of the hand: current role of sympathetic skin response and three-phase bone scintigraphy. Journal of Orthopaedic Surgery 14(3): 284-290, 2007

The use of regional intra vascular sympathetic block with guanethidine ismelin as an adjunct to the treatment of post traumatic disturbances of function of the hand. Orthopaedic Transactions 6(2): 161-162, 1982

Regional intravenous guanethidine blocks in algodystrophy. Clinical Rheumatology 10(4): 377-383, 1991

Intravenous regional block with phentolamine in the treatment of complex regional pain syndrome. Acta Medica Iranica 49(8): 523-526, 2012

Intravenous regional block with lidocaine for treatment of complex regional pain syndrome. Clinical Journal of Pain 22(2): 222-224, 2006

Objective improvements in algodystrophy following regional intravenous guanethidine. Journal of Hand Surgery 18(3): 339-342, 1993

Intravenous magnesium sulphate for the treatment of pain in Complex Regional Pain Syndrome type 1 (CRPS1): A pilot study. European Journal of Anaesthesiology 25(Sup 44): 211-212, 2008